Chemoinformaics analysis of 5-O-methyldroserone
Molecular Weight | 218.208 | nRot | 1 |
Heavy Atom Molecular Weight | 208.128 | nRig | 14 |
Exact Molecular Weight | 218.058 | nRing | 2 |
Solubility: LogS | -3.804 | nHRing | 0 |
Solubility: LogP | 1.459 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 29.9159 |
nHD | 1 | BPOL | 13.5041 |
QED | 0.526 |
Synth | 2.838 |
Natural Product Likeliness | 0.762 |
NR-PPAR-gamma | 0.023 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.041 |
Pgp-sub | 0.001 |
HIA | 0.004 |
CACO-2 | -4.595 |
MDCK | 0.0000353 |
BBB | 0.466 |
PPB | 0.923883 |
VDSS | 0.589 |
FU | 0.0158594 |
CYP1A2-inh | 0.958 |
CYP1A2-sub | 0.812 |
CYP2c19-inh | 0.306 |
CYP2c19-sub | 0.448 |
CYP2c9-inh | 0.237 |
CYP2c9-sub | 0.476 |
CYP2d6-inh | 0.192 |
CYP2d6-sub | 0.42 |
CYP3a4-inh | 0.272 |
CYP3a4-sub | 0.249 |
CL | 4.402 |
T12 | 0.275 |
hERG | 0.012 |
Ames | 0.684 |
ROA | 0.14 |
SkinSen | 0.278 |
Carcinogencity | 0.602 |
EI | 0.245 |
Respiratory | 0.358 |
NR-Aromatase | 0.064 |
Antiviral | No |
Prediction | 0.711218 |